APA

Zamora M. R., Fullerton D. A., Campbell D. N., Leone S., Diercks M. J., Fisher J. H., Badesch D. B. & Grover F. L. (19941114). Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. : Transplantation proceedings.

Chicago

Zamora M R, Fullerton D A, Campbell D N, Leone S, Diercks M J, Fisher J H, Badesch D B and Grover F L. 19941114. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. : Transplantation proceedings.

Harvard

Zamora M. R., Fullerton D. A., Campbell D. N., Leone S., Diercks M. J., Fisher J. H., Badesch D. B. and Grover F. L. (19941114). Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. : Transplantation proceedings.

MLA

Zamora M R, Fullerton D A, Campbell D N, Leone S, Diercks M J, Fisher J H, Badesch D B and Grover F L. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. : Transplantation proceedings. 19941114.